Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Gravesʼ orbitopathy (MINGO): a randomised, observer-masked, multicentre trial - Kahaly, G J; Riedl, M; Konig, J (Lancet Diabetes Endocrinol, 2018)